Schizophrenia, ???Just the Facts??? What we know in 2008. 2. Epidemiology and etiology, Schizophrenia Research, vol.102, issue.1-3, pp.1-31, 2008. ,
DOI : 10.1016/j.schres.2008.04.011
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis, Lancet. 20 avr, vol.381, issue.9875, pp.1371-1379, 2013. ,
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study, The Lancet, vol.373, issue.9659, pp.234-239, 2009. ,
DOI : 10.1016/S0140-6736(09)60072-6
The Kraepelinian dichotomy - going, going... but still not gone, The British Journal of Psychiatry, vol.196, issue.2, pp.92-95, 2010. ,
DOI : 10.1192/bjp.bp.109.073429
Epidemiological and Clinical Characterization Following a First Psychotic Episode in Major Depressive Disorder: Comparisons With Schizophrenia and Bipolar I Disorder in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS), Schizophrenia Bulletin, vol.39, issue.4, pp.756-765, 2013. ,
DOI : 10.1093/schbul/sbt075
Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis, Schizophrenia Research, vol.141, issue.2-3, pp.2-3222, 2012. ,
DOI : 10.1016/j.schres.2012.08.019
Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?, Journal of Neural Transmission, vol.13, issue.Suppl 2, pp.1199-1215, 2007. ,
DOI : 10.1007/s00702-007-0742-4
Neuroleptics and the Natural Course of Schizophrenia, Schizophrenia Bulletin, vol.17, issue.2, pp.325-351, 1991. ,
DOI : 10.1093/schbul/17.2.325
Are some cases of psychosis caused by microbial agents? A review of the evidence, Molecular Psychiatry, vol.23, issue.5, pp.470-479, 2008. ,
DOI : 10.1128/AAC.00793-06
The environment and schizophrenia, Nature, vol.65, issue.7321, pp.203-212, 2010. ,
DOI : 10.1038/nature09563
The antecedents of psychoses: a case???control study of selected risk factors, Schizophrenia Research, vol.46, issue.1, pp.17-23, 2000. ,
DOI : 10.1016/S0920-9964(99)00237-6
Les facteurs de risque environnementaux de la schizophr??nie, L'Enc??phale, vol.39, issue.1, pp.19-28, 2013. ,
DOI : 10.1016/j.encep.2011.12.007
Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism, Developmental Neurobiology, vol.28, issue.10, pp.1272-1276, 2012. ,
DOI : 10.1002/dneu.22024
Gestational Influenza and Bipolar Disorder in Adult Offspring, JAMA Psychiatry, vol.70, issue.7, pp.677-685, 2013. ,
DOI : 10.1001/jamapsychiatry.2013.896
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies, American Journal of Psychiatry, vol.167, issue.3, pp.261-280, 2010. ,
DOI : 10.1176/appi.ajp.2009.09030361
Toxoplasma gondii and Other Risk Factors for Schizophrenia: An Update, Schizophrenia Bulletin, vol.38, issue.3, pp.642-647, 2012. ,
DOI : 10.1093/schbul/sbs043
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329973
Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample, Journal of Affective Disorders, vol.148, issue.2-3, pp.2-3444, 2013. ,
DOI : 10.1016/j.jad.2012.11.034
Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts, Journal of Affective Disorders, vol.130, issue.1-2, pp.220-225, 2011. ,
DOI : 10.1016/j.jad.2010.09.029
Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder, Biological Psychiatry, vol.55, issue.6, pp.588-593, 2004. ,
DOI : 10.1016/j.biopsych.2003.10.008
Deficit Schizophrenia: Association With Serum Antibodies to Cytomegalovirus, Schizophrenia Bulletin, vol.32, issue.2, pp.396-400, 2006. ,
DOI : 10.1093/schbul/sbi054
Prenatal infection and cavum septum pellucidum in adult schizophrenia, Schizophrenia Research, vol.108, issue.1-3, pp.1-3285, 2009. ,
DOI : 10.1016/j.schres.2008.11.018
Prenatal Exposure to Maternal Infection and Executive Dysfunction in Adult Schizophrenia, American Journal of Psychiatry, vol.166, issue.6, pp.683-690, 2009. ,
DOI : 10.1176/appi.ajp.2008.08010089
Cytomegalovirus seropositivity and serointensity are associated with hippocampal volume and verbal memory in schizophrenia and bipolar disorder, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.48, pp.142-148, 2014. ,
DOI : 10.1016/j.pnpbp.2013.09.003
URL : https://hal.archives-ouvertes.fr/inserm-00877593
Schizophrenia Susceptibility Genes Directly Implicated in the Life Cycles of Pathogens: Cytomegalovirus, Influenza, Herpes simplex, Rubella, and Toxoplasma gondii, Schizophrenia Bulletin, vol.35, issue.6, pp.1163-1182, 2009. ,
DOI : 10.1093/schbul/sbn054
Human endogenous retrovirus type W (HERV-W) in schizophrenia: A new avenue of research at the gene???environment interface, The World Journal of Biological Psychiatry, vol.107, issue.1, pp.80-90, 2013. ,
DOI : 10.1111/j.1468-1331.2009.02552.x
Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorder, Translational Psychiatry, vol.38, issue.12, p.201, 2012. ,
DOI : 10.1038/nm0510-517
URL : https://hal.archives-ouvertes.fr/inserm-00807038
Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH, Proceedings of the National Academy of Sciences, vol.110, issue.48, 2013. ,
DOI : 10.1073/pnas.1318172110
Common variants conferring risk of schizophrenia, Nature, vol.155, issue.7256, pp.744-747, 2009. ,
DOI : 10.1038/nature08186
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder, Nature. 6 août, vol.460, issue.7256, pp.748-752, 2009. ,
Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers, Molecular Brain Research, vol.139, issue.2, pp.317-332, 2005. ,
DOI : 10.1016/j.molbrainres.2005.06.006
Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.15533-15538, 2005. ,
DOI : 10.1073/pnas.0507666102
Inflammation-related genes up-regulated in schizophrenia brains, BMC Psychiatry, vol.64, issue.6, p.46, 2007. ,
DOI : 10.4088/JCP.v64n0618e
Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: Associations and functional implications, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.42, pp.49-62, 2013. ,
DOI : 10.1016/j.pnpbp.2012.07.009
MHC class I modulates NMDA receptor function and AMPA receptor trafficking, Proceedings of the National Academy of Sciences, vol.107, issue.51, pp.22278-22283, 2010. ,
DOI : 10.1073/pnas.0914064107
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009822
Association of Tumor Necrosis Factor –308G/A Promoter Polymorphism with Schizophrenia and Bipolar Affective Disorder in a Polish Population, Neuropsychobiology, vol.57, issue.1-2, pp.88-94, 2008. ,
DOI : 10.1159/000135642
The MCP-1 Gene (SCYA2) and Mood Disorders: Preliminary Results of a Case-Control Association Study, Neuroimmunomodulation, vol.17, issue.2, pp.126-131, 2010. ,
DOI : 10.1159/000258696
Monocyte chemoattractant protein-1 in schizophrenia: ???2518A/G genetic variant and protein levels in Armenian population, Cytokine, vol.58, issue.3, pp.351-354, 2012. ,
DOI : 10.1016/j.cyto.2012.02.013
Polymorphism of Toll-like receptor 4 gene in bipolar disorder, Journal of Affective Disorders, vol.152, issue.154, pp.152-154395, 2014. ,
DOI : 10.1016/j.jad.2013.09.043
The HLA-G low expressor genotype is associated with protection against bipolar disorder, Human Immunology, vol.74, issue.5, pp.593-597, 2013. ,
DOI : 10.1016/j.humimm.2012.11.032
URL : https://hal.archives-ouvertes.fr/inserm-00864639
Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder, The Journal of Clinical Psychiatry, vol.70, issue.8, pp.1078-1090, 2009. ,
DOI : 10.4088/JCP.08r04505
Preliminary Findings Regarding Overweight and Obesity in Pediatric Bipolar Disorder, The Journal of Clinical Psychiatry, vol.69, issue.12, 1953. ,
DOI : 10.4088/JCP.v69n1215
Can bipolar disorder be viewed as a multi-system inflammatory disease?, Journal of Affective Disorders, vol.141, issue.1, pp.1-10, 2012. ,
DOI : 10.1016/j.jad.2011.12.049
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498820
Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients, Psychological Medicine, vol.156, issue.09, pp.1893-1901, 2012. ,
DOI : 10.1016/j.biopsych.2008.05.018
C-Reactive Protein Levels in Schizophrenia, Clinical Schizophrenia & Related Psychoses, vol.7, issue.4, 2013. ,
DOI : 10.3371/CSRP.MICU.020813
Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.31, issue.4, pp.952-955, 2007. ,
DOI : 10.1016/j.pnpbp.2007.02.018
Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs, Psychiatry Research, vol.66, issue.1, pp.1-11, 1997. ,
DOI : 10.1016/S0165-1781(96)02915-0
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects, Biological Psychiatry, vol.70, issue.7, pp.663-671, 2011. ,
DOI : 10.1016/j.biopsych.2011.04.013
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies, Biological Psychiatry, vol.74, issue.1, pp.15-25, 2013. ,
DOI : 10.1016/j.biopsych.2013.01.007
Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects, Biological Psychiatry, vol.73, issue.10, pp.993-999, 2013. ,
DOI : 10.1016/j.biopsych.2012.09.007
Abnormal distributions of T-lymphocyte subsets in the cerebrospinal fluid of patients with acute schizophrenia, Schizophrenia Research, vol.14, issue.3, pp.215-221, 1995. ,
DOI : 10.1016/0920-9964(94)00039-B
Accumulation of Macrophages in the CSF of Schizophrenic Patients During Acute Psychotic Episodes, Am J Psychiatry. 1 nov, vol.156, issue.11, pp.1725-1729, 1999. ,
The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder, Expert Review of Neurotherapeutics, vol.10, issue.1, pp.59-76, 2010. ,
DOI : 10.1586/ern.09.144
The Role of Microglia in the Healthy Brain, Journal of Neuroscience, vol.31, issue.45, pp.16064-16069, 2011. ,
DOI : 10.1523/JNEUROSCI.4158-11.2011
Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain, Annals of Neurology, vol.43, issue.4, pp.536-549, 2012. ,
DOI : 10.1002/ana.23626
The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence, Medical Hypotheses, vol.45, issue.2, pp.135-141, 1995. ,
DOI : 10.1016/0306-9877(95)90062-4
The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms, Medical Hypotheses, vol.56, issue.4, pp.483-486, 2001. ,
DOI : 10.1054/mehy.2000.1203
Cytokines and schizophrenia: Microglia hypothesis of schizophrenia, Psychiatry and Clinical Neurosciences, vol.12, issue.3, pp.257-265, 2009. ,
DOI : 10.1111/j.1440-1819.2009.01945.x
A systematic, quantitative review of blood autoantibodies in schizophrenia, Schizophrenia Research, vol.150, issue.1, pp.245-251, 2013. ,
DOI : 10.1016/j.schres.2013.07.029
Characteristics of Autoimmune Disease, Journal of Investigative Dermatology, vol.96, issue.5, pp.87-87, 1991. ,
DOI : 10.1111/1523-1747.ep12472162
The Epidemiologic Evidence Linking Autoimmune Diseases and Psychosis, Biological Psychiatry, vol.75, issue.4, pp.300-306, 2014. ,
DOI : 10.1016/j.biopsych.2013.09.023
Increased prevalence of antibrain antibodies in the sera from schizophrenic patients, Schizophrenia Research, vol.14, issue.1, pp.15-22, 1994. ,
DOI : 10.1016/0920-9964(94)90004-3
Phenothiazine Effect on Human Antibody Synthesis, The British Journal of Psychiatry, vol.110, issue.464, pp.84-89, 1964. ,
DOI : 10.1192/bjp.110.464.84
Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii, Schizophrenia Research, vol.62, issue.3, pp.237-244, 2003. ,
DOI : 10.1016/S0920-9964(02)00357-2
Evaluation of Five Antischizophrenic Agents Against Toxoplasma gondii in Human Cell Cultures, Journal of Parasitology, vol.97, issue.1, pp.148-151, 2011. ,
DOI : 10.1645/GE-2536.1
Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate, European Archives of Psychiatry and Clinical Neuroscience, vol.31, issue.2, pp.179-183, 2014. ,
DOI : 10.1007/s00406-013-0413-4
URL : https://hal.archives-ouvertes.fr/inserm-00844714
A possible antiviral action of lithium carbonate in herpes simplex virus infections, Biological Psychiatry, vol.27, issue.4, pp.447-453, 1990. ,
DOI : 10.1016/0006-3223(90)90555-G
Effect of Selected Neuroleptic Agents and Stereo-Isomeric Analogues on Virus and Eukaryotic Cells, Pharmacology & Toxicology, vol.50, issue.No. 12, pp.399-403, 1991. ,
DOI : 10.1111/j.1600-0773.1991.tb01260.x
Antipsychotics' effects on blood levels of cytokines in schizophrenia: a metaanalysis, Schizophr Res. déc, vol.151, pp.1-343, 2013. ,
The effects of lithium on ex vivo cytokine production, Biological Psychiatry, vol.50, issue.3, pp.217-224, 2001. ,
DOI : 10.1016/S0006-3223(01)01144-1
Risperidone significantly inhibits interferon-??-induced microglial activation in vitro, Schizophrenia Research, vol.92, issue.1-3, pp.1-3108, 2007. ,
DOI : 10.1016/j.schres.2007.01.019
Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus, Rheumatology International, vol.125, issue.suppl, 1923. ,
DOI : 10.1007/s00296-013-2750-z
Manic Induction with Interferon Alpha Therapy, Australian & New Zealand Journal of Psychiatry, vol.25, issue.11, p.1004, 2011. ,
DOI : 10.1038/clpt.1981.154
Psychosis Induced by Interferon-??, Psychosomatics, vol.43, issue.5, pp.428-429, 2002. ,
DOI : 10.1176/appi.psy.43.5.428
Acute psychosis in three patients receiving anti-tumour necrosis factor-?? therapy, Rheumatology, vol.47, issue.8, pp.1254-1255, 2008. ,
DOI : 10.1093/rheumatology/ken212
Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid, Dis Chest. avr, vol.21, issue.4, pp.385-438, 1952. ,
Anti-inflammatory treatment in schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.42, pp.146-153, 2013. ,
DOI : 10.1016/j.pnpbp.2012.11.008
Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review, Acta Psychiatrica Scandinavica, vol.10, issue.Suppl 3, pp.163-179, 2014. ,
DOI : 10.1111/acps.12211
COX-2 inhibition as a treatment approach in schizophrenia: Immunological considerations and clinical effects of celecoxib add-on therapy, European Archives of Psychiatry and Clinical Neuroscience, vol.254, issue.1, pp.14-22, 2004. ,
DOI : 10.1007/s00406-004-0478-1
Rationale for a trial of immunosuppressive therapy in acute schizophrenia, Molecular Psychiatry, vol.37, issue.5, pp.424-431, 2007. ,
DOI : 10.1038/sj.mp.4001959
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression, JAMA Psychiatry, vol.70, issue.1, pp.31-41, 2013. ,
DOI : 10.1001/2013.jamapsychiatry.4
Disease-relevant autoantibodies in first episode schizophrenia, Journal of Neurology, vol.13, issue.4, pp.686-688, 2011. ,
DOI : 10.1007/s00415-010-5788-9
NMDA receptors in clinical neurology: excitatory times ahead, The Lancet Neurology, vol.7, issue.8, pp.742-755, 2008. ,
DOI : 10.1016/S1474-4422(08)70165-0
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease, Nature Reviews Neuroscience, vol.135, issue.6, pp.383-400, 2013. ,
DOI : 10.1038/nrn3504
N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?, Brain Research Bulletin, vol.83, issue.3-4, pp.3-4108, 2010. ,
DOI : 10.1016/j.brainresbull.2010.04.006
Regulation of Calcium/Calmodulin-dependent Protein Kinase II Docking toN-Methyl-D-aspartate Receptors by Calcium/Calmodulin and ??-Actinin, Journal of Biological Chemistry, vol.277, issue.50, pp.48441-48448, 2002. ,
DOI : 10.1074/jbc.M205164200
Selectivity and Promiscuity of the First and Second PDZ Domains of PSD-95 and Synapse-associated Protein 102, Journal of Biological Chemistry, vol.277, issue.24, pp.21697-21711, 2002. ,
DOI : 10.1074/jbc.M112339200
EphB Receptors Interact with NMDA Receptors and Regulate Excitatory Synapse Formation, Cell, vol.103, issue.6, pp.945-956, 2000. ,
DOI : 10.1016/S0092-8674(00)00197-5
URL : http://doi.org/10.1016/s0092-8674(00)00197-5
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment, Neuropsychopharmacology, vol.35, issue.1, pp.4-15, 2012. ,
DOI : 10.1073/pnas.76.10.5372
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia, Neuroscience Letters, vol.20, issue.3 ,
DOI : 10.1016/0304-3940(80)90178-0
Low Cerebrospinal Fluid Glutamate and Glycine in Refractory Affective Disorder, Biological Psychiatry, vol.61, issue.2, pp.162-166, 2007. ,
DOI : 10.1016/j.biopsych.2006.01.024
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial, Nature Medicine, vol.43, issue.9, pp.1102-1107, 2007. ,
DOI : 10.1038/nm1632
A Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of a Metabotropic Glutamate 2/3 Receptor Agonist Using an Electronic Patient-Reported Outcome Device in Patients With Schizophrenia, Journal of Clinical Psychopharmacology, vol.34, issue.5, 2014. ,
DOI : 10.1097/JCP.0000000000000187
Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia, Biological Psychiatry, vol.53, issue.7, pp.617-619, 2003. ,
DOI : 10.1016/S0006-3223(02)01783-3
Nmethyl-d-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels, Schizophr Res. juin, vol.84, pp.2-3214, 2006. ,
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database, Nature Genetics, vol.315, issue.7, pp.827-834, 2008. ,
DOI : 10.1177/1740774507079441
An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray, European Journal of Human Genetics, vol.59, issue.7, pp.807-814, 2005. ,
DOI : 10.1161/01.CIR.0000124487.36586.26
NMDA receptors and schizophrenia, Current Opinion in Pharmacology, vol.7, issue.1, pp.48-55, 2007. ,
DOI : 10.1016/j.coph.2006.08.013
The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment, Current Neuropharmacology, vol.12, issue.3, pp.219-238, 2014. ,
DOI : 10.2174/1570159X12666140324183406
Glutamate as a therapeutic target in psychiatric disorders, Molecular Psychiatry, vol.9, issue.11, pp.984-997, 2004. ,
DOI : 10.1038/sj.mp.4001551
Add-on Treatment of Benzoate for Schizophrenia, JAMA Psychiatry, vol.70, issue.12, pp.1267-1275, 2013. ,
DOI : 10.1001/jamapsychiatry.2013.2159
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression, Nature, vol.12, issue.7231, pp.910-914, 2009. ,
DOI : 10.1038/nature07762
)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia, Journal of Medicinal Chemistry, vol.53, issue.12, pp.4603-4614, 2010. ,
DOI : 10.1021/jm100210p
Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia, JAMA Psychiatry, vol.71, issue.6, pp.637-646, 2014. ,
DOI : 10.1001/jamapsychiatry.2014.163
A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia ??? Results from the CandleLyte study, European Neuropsychopharmacology, vol.24, issue.7, pp.1024-1036, 2014. ,
DOI : 10.1016/j.euroneuro.2014.03.007
Contributions of the d-serine pathway to schizophrenia, Neuropharmacology, vol.62, issue.3, pp.1484-1503, 2012. ,
DOI : 10.1016/j.neuropharm.2011.01.030
Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine, Biological Psychiatry, vol.65, issue.12, pp.1103-1106, 2009. ,
DOI : 10.1016/j.biopsych.2009.01.002
Cystine/Glutamate Exchange Modulates Glutathione Supply for Neuroprotection from Oxidative Stress and Cell Proliferation, Journal of Neuroscience, vol.26, issue.41, pp.10514-10523, 2006. ,
DOI : 10.1523/JNEUROSCI.3178-06.2006
Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A ???central hub??? in schizophrenia pathophysiology?, Schizophrenia Research, vol.176, issue.1, 2014. ,
DOI : 10.1016/j.schres.2014.06.021
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update, Schizophrenia Bulletin, vol.40, issue.1, pp.181-191, 2014. ,
DOI : 10.1093/schbul/sbt139
Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator, European Journal of Pharmacology, vol.659, issue.2-3, pp.2-3146, 2011. ,
DOI : 10.1016/j.ejphar.2011.02.003
Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration, Neuropharmacology, vol.62, issue.3, pp.1453-1460, 2012. ,
DOI : 10.1016/j.neuropharm.2010.11.013
Mechanism based neurotoxicity of mGlu5 positive allosteric modulators ??? Development challenges for a promising novel antipsychotic target, Neuropharmacology, vol.82, pp.161-173, 2014. ,
DOI : 10.1016/j.neuropharm.2012.12.003
Extracellular matrix abnormalities in schizophrenia, Neuropharmacology, vol.62, issue.3, pp.1584-1597, 2012. ,
DOI : 10.1016/j.neuropharm.2011.08.010
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234338
Emerging role of glutamate in the pathophysiology of major depressive disorder, Brain Research Reviews, vol.61, issue.2, pp.105-123, 2009. ,
DOI : 10.1016/j.brainresrev.2009.05.005
The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects, Current Psychiatry Reports, vol.64, issue.Suppl, pp.467-474, 2007. ,
DOI : 10.1007/s11920-007-0063-1
Ketamine administration in depressive disorders: a systematic review and metaanalysis . Psychopharmacology (Berl), 2014. ,
From inflammation to sickness and depression: when the immune system subjugates the brain, Nature Reviews Neuroscience, vol.17, issue.1, pp.46-56, 2008. ,
DOI : 10.1038/nrn2297
Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood???brain barrier integrity, The World Journal of Biological Psychiatry, vol.15, issue.2, pp.482-492, 2012. ,
DOI : 10.1038/sj.mp.4000813
Toxoplasma gondii and Schizophrenia: Linkage Through Astrocyte-Derived Kynurenic Acid?, Schizophrenia Bulletin, vol.33, issue.3, pp.652-653, 2007. ,
DOI : 10.1093/schbul/sbm030
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526138
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia, Neuroscience Letters, vol.313, issue.1-2, pp.96-98, 2001. ,
DOI : 10.1016/S0304-3940(01)02242-X
Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia, Schizophrenia Research, vol.80, issue.2-3, pp.2-3315, 2005. ,
DOI : 10.1016/j.schres.2005.07.013
Kynurenine pathway in major depression: Evidence of impaired neuroprotection, Journal of Affective Disorders, vol.98, issue.1-2, pp.143-151, 2007. ,
DOI : 10.1016/j.jad.2006.07.013
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-??: relationship to CNS immune responses and depression, Molecular Psychiatry, vol.1, issue.4, pp.393-403, 2010. ,
DOI : 10.1016/S0893-133X(01)00407-9
-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma, Annals of Neurology, vol.127, issue.1, pp.25-36, 2007. ,
DOI : 10.1002/ana.21050
URL : https://hal.archives-ouvertes.fr/hal-00408663
SUBACUTE ENCEPHALITIS OF LATER ADULT LIFE. MAINLY AFFECTING THE LIMBIC AREAS, Brain, vol.83, issue.3, pp.357-368, 1960. ,
DOI : 10.1093/brain/83.3.357
???LIMBIC ENCEPHALITIS??? AND ITS ASSOCIATION WITH CARCINOMA, Brain, vol.91, issue.3, pp.481-496, 1968. ,
DOI : 10.1093/brain/91.3.481
Mesencephalitis and Rhombencephalitis, BMJ, vol.2, issue.4723, pp.77-81, 1951. ,
DOI : 10.1136/bmj.2.4723.77
Insights into antibody-associated encephalitis ??? Bickerstaff's 1950's papers revisited, Journal of the Neurological Sciences, vol.334, issue.1-2, 2013. ,
DOI : 10.1016/j.jns.2013.07.010
Antibodies and neuronal autoimmune disorders of the CNS, Journal of Neurology, vol.66, issue.Suppl 13, pp.509-517, 2010. ,
DOI : 10.1007/s00415-009-5431-9
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma, Annals of Neurology, vol.365, issue.4, pp.594-604, 2005. ,
DOI : 10.1002/ana.20614
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, The Lancet Neurology, vol.7, issue.12, pp.1091-1098, 2008. ,
DOI : 10.1016/S1474-4422(08)70224-2
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study, The Lancet Infectious Diseases, vol.10, issue.12, pp.835-879, 2010. ,
DOI : 10.1016/S1473-3099(10)70222-X
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series, The Lancet Neurology, vol.9, issue.8, pp.776-785, 2010. ,
DOI : 10.1016/S1474-4422(10)70137-X
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia, Brain, vol.133, issue.9, pp.2734-2748, 2010. ,
DOI : 10.1093/brain/awq213
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location, Annals of Neurology, vol.7, issue.pt 7, pp.424-434, 2009. ,
DOI : 10.1002/ana.21589
Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome, Neurology, vol.77, issue.18, pp.1698-701, 2011. ,
DOI : 10.1212/WNL.0b013e3182364a44
Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen, The Lancet Neurology, vol.9, issue.1, pp.67-76, 2010. ,
DOI : 10.1016/S1474-4422(09)70324-2
Antiglycine-receptor encephalomyelitis with rigidity, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.12, pp.1399-1401, 2011. ,
DOI : 10.1136/jnnp.2010.229104
URL : http://jnnp.bmj.com/cgi/content/short/82/12/1399
The Frequency of Autoimmune N-Methyl-D-Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis Project, Clinical Infectious Diseases, vol.54, issue.7, pp.899-904, 2012. ,
DOI : 10.1093/cid/cir1038
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study, The Lancet Neurology, vol.12, issue.2, pp.157-165, 2013. ,
DOI : 10.1016/S1474-4422(12)70310-1
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis, The Lancet Neurology, vol.10, issue.1, pp.63-74, 2011. ,
DOI : 10.1016/S1474-4422(10)70253-2
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, The Lancet Neurology, vol.7, issue.12, pp.1091-1098, 2008. ,
DOI : 10.1016/S1474-4422(08)70224-2
Pseudopseudoseizures: Conditions That May Mimic Psychogenic Non-Epileptic Seizures, Psychosomatics, vol.52, issue.6, pp.501-506, 2011. ,
DOI : 10.1016/j.psym.2011.08.004
Encéphalites auto-immunes à anticorps anti-récepteurs NMDA, une cause fréquente d'encéphalite en réanimation. Réanimation SRLF, 2011. ,
DOI : 10.1007/s13546-011-0275-6
-Aspartate Receptor Encephalitis, JAMA Neurology, vol.70, issue.9, pp.1133-1139, 2013. ,
DOI : 10.1001/jamaneurol.2013.3216
URL : https://hal.archives-ouvertes.fr/hal-00504990
Extreme delta brush in a patient with anti-NMDAR encephalitis, Epileptic Disord Int Epilepsy J Videotape. déc, vol.15, issue.4, pp.461-464, 2013. ,
Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study, Journal of Neurology, vol.30, issue.10, pp.1686-1691, 2010. ,
DOI : 10.1007/s00415-010-5604-6
-acetylaspartate in the basal ganglia of a patient with anti-NMDA receptor encephalitis, Movement Disorders, vol.880, issue.5, pp.784-786, 2009. ,
DOI : 10.1002/mds.22167
URL : https://hal.archives-ouvertes.fr/in2p3-00461069
Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal, Neurology, vol.70, issue.7, pp.504-511, 2008. ,
DOI : 10.1212/01.wnl.0000278388.90370.c3
Cortical Hypometabolism Demonstrated by PET in Relapsing NMDA Receptor Encephalitis, Pediatric Neurology, vol.43, issue.3, pp.217-220, 2010. ,
DOI : 10.1016/j.pediatrneurol.2010.04.019
FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.2, pp.235-236, 2011. ,
DOI : 10.1136/jnnp.2009.198697
Abnormal multifocal cerebral blood flow on Tc-99m HMPAO SPECT in a patient with anti-NMDA-receptor encephalitis, Journal of Neurology, vol.3, issue.9, pp.1568-1569, 2010. ,
DOI : 10.1007/s00415-010-5546-z
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study, The Lancet Neurology, vol.13, issue.2, pp.167-177, 2014. ,
DOI : 10.1016/S1474-4422(13)70282-5
Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes, Journal of the Neurological Sciences, vol.295, issue.1-2, pp.87-91, 2010. ,
DOI : 10.1016/j.jns.2010.04.016
A patient with epilepsia partialis continua with anti-glutamate receptor ??2 antibodies, Pediatric Neurology, vol.29, issue.2, pp.160-163, 2003. ,
DOI : 10.1016/S0887-8994(03)00151-6
Autoantibodies and Cell-mediated Autoimmunity to NMDA-type GluRe2 in Patients with Rasmussen's Encephalitis and Chronic Progressive Epilepsia Partialis Continua, Epilepsia, vol.13, issue.s5, pp.152-158, 2005. ,
DOI : 10.1002/ana.10100
Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis, Biological Psychiatry, vol.75, issue.4, pp.284-291, 2014. ,
DOI : 10.1016/j.biopsych.2013.07.018
NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease, Journal of Neurology, vol.59, issue.9, 1979. ,
DOI : 10.1007/s00415-012-6489-3
Pearls & Oy-sters: Electroconvulsive therapy in anti-NMDA receptor encephalitis, Neurology, vol.75, issue.10, pp.44-46, 2010. ,
DOI : 10.1212/WNL.0b013e3181f11dc1
Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity, Mol Psychiatry, 2013. ,
Amantadine Inhibits NMDA Receptors by Accelerating Channel Closure during Channel Block, Journal of Neuroscience, vol.25, issue.13, pp.3312-3322, 2005. ,
DOI : 10.1523/JNEUROSCI.4262-04.2005
Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis, European Journal of Clinical Microbiology & Infectious Diseases, vol.66, issue.1, pp.1421-1429, 2009. ,
DOI : 10.1007/s10096-009-0799-0
-aspartate receptor antibodies in herpes simplex encephalitis, Annals of Neurology, vol.10, issue.6, pp.902-911, 2012. ,
DOI : 10.1002/ana.23689
Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: Case report, Neurology, vol.81, issue.18, pp.1637-1639, 2013. ,
DOI : 10.1212/WNL.0b013e3182a9f531
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806918
Clinical Neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-Daspartate receptor antibodies are part of the problem, Clinical Neuropathology, vol.32, issue.07, pp.251-254, 2013. ,
DOI : 10.5414/NP300666
Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies, European Journal of Neuroscience, vol.36, issue.202, pp.298-309, 2010. ,
DOI : 10.1111/j.1460-9568.2010.07349.x
Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression, Am J Physiol Heart Circ Physiol. mars, vol.280, issue.3, pp.1241-1248, 2001. ,
Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood???brain barrier without inducing reactive gliosis, Brain Research, vol.832, issue.1-2, pp.84-96, 1999. ,
DOI : 10.1016/S0006-8993(99)01479-1
Corticotropin-Releasing Hormone and Brain Mast Cells Regulate Blood-Brain-Barrier Permeability Induced by Acute Stress, Journal of Pharmacology and Experimental Therapeutics, vol.303, issue.3, pp.1061-1066, 2002. ,
DOI : 10.1124/jpet.102.038497
Immunity and behavior: Antibodies alter emotion, Proceedings of the National Academy of Sciences, vol.103, issue.3, pp.678-683, 2006. ,
DOI : 10.1073/pnas.0510055103
Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption, Cancer Res. 1 sept, vol.48, issue.17, pp.4725-4729, 1988. ,
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis, Journal of Neuroscience, vol.30, issue.17, pp.5866-5875, 2010. ,
DOI : 10.1523/JNEUROSCI.0167-10.2010
Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis, Brain, vol.135, issue.5, pp.1606-1621, 2012. ,
DOI : 10.1093/brain/aws092
URL : https://hal.archives-ouvertes.fr/hal-01160045
Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients, Neurobiology of Disease, vol.45, issue.1, pp.610-615, 2012. ,
DOI : 10.1016/j.nbd.2011.09.019
Internalization at glutamatergic synapses during development, European Journal of Neuroscience, vol.267, issue.12, pp.3207-3217, 2003. ,
DOI : 10.1016/S0896-6273(00)81066-1
Surface trafficking of receptors between synaptic and extrasynaptic membranes: and yet they do move!, Trends in Neurosciences, vol.28, issue.3, pp.133-139, 2005. ,
DOI : 10.1016/j.tins.2005.01.001
The Receptor Tyrosine Kinase EphB2 Regulates NMDA-Dependent Synaptic Function, Neuron, vol.32, issue.6, pp.1041-1056, 2001. ,
DOI : 10.1016/S0896-6273(01)00553-0
EphB Controls NMDA Receptor Function and Synaptic Targeting in a Subunit-Specific Manner, Journal of Neuroscience, vol.31, issue.14, pp.5353-5364, 2011. ,
DOI : 10.1523/JNEUROSCI.0282-11.2011
Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis, Psychological Medicine, vol.7, issue.12, 2013. ,
DOI : 10.1038/npp.2010.163
Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis, Journal of Neuroimmunology, vol.231, issue.1-2, pp.86-91, 2011. ,
DOI : 10.1016/j.jneuroim.2010.09.012
Subunit of the NMDA Receptor Not Detected in Schizophrenia, American Journal of Psychiatry, vol.169, issue.10, pp.1120-1121, 2012. ,
DOI : 10.1176/appi.ajp.2012.12050646
Late onset autism and anti-NMDA-receptor encephalitis, The Lancet, vol.378, issue.9785, p.98, 2011. ,
DOI : 10.1016/S0140-6736(11)60548-5
NMDA) receptor encephalitis: an unusual cause of autistic regression in a toddler, J Child Neurol. mai, vol.29, issue.5, pp.691-694, 2014. ,
A clinical and neurobiological case of IgM NMDA receptor antibody associated encephalitis mimicking bipolar disorder, Psychiatry Research, vol.208, issue.2, pp.194-196, 2013. ,
DOI : 10.1016/j.psychres.2012.09.035
Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of Schizophrenia, JAMA Psychiatry, vol.70, issue.3, pp.271-278, 2013. ,
DOI : 10.1001/2013.jamapsychiatry.86
Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features, BMC Psychiatry, vol.61, issue.10, p.37, 2012. ,
DOI : 10.1016/S0169-328X(98)00211-3
Seroprevalence of n-methyl-d-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients, European Archives of Psychiatry and Clinical Neuroscience, vol.35, issue.2 ,
DOI : 10.1007/s00406-014-0493-9
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment, Neurology, vol.78, issue.22, pp.1743-1753, 2012. ,
DOI : 10.1212/WNL.0b013e318258300d
Systemic lupus erythematosus, the brain, and anti-NR2 antibodies, Journal of Neurology, vol.54, issue.10, pp.622-629, 2012. ,
DOI : 10.1007/s00415-011-6232-5
Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors, European Journal of Neurology, vol.41, issue.5, pp.392-398, 2005. ,
DOI : 10.1038/373151a0
Antibodies to the glutamate receptor in mania, Bipolar Disorders, vol.16, issue.5, pp.547-53, 2012. ,
DOI : 10.1111/j.1399-5618.2012.01028.x
A Combined Marker of Inflammation in Individuals with Mania, PLoS ONE, vol.494, issue.9, p.73520, 2013. ,
DOI : 10.1371/journal.pone.0073520.t002
Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review, Biological Psychiatry, vol.63, issue.8, pp.801-808, 2008. ,
DOI : 10.1016/j.biopsych.2007.09.024
Updating the mild encephalitis hypothesis of schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.42, pp.71-91, 2013. ,
DOI : 10.1016/j.pnpbp.2012.06.019
Antibodies to NMDA receptor, blood???brain barrier disruption and schizophrenia: a theory with unproven links, Molecular Psychiatry, vol.253, issue.10, 2014. ,
DOI : 10.1016/S1474-4422(13)70282-5
Neuroinflammation and psychiatric illness, Journal of Neuroinflammation, vol.31, issue.1, p.43, 2013. ,
DOI : 10.1186/1742-2094-10-43
URL : http://doi.org/10.1186/1742-2094-10-43
Autoantibodies associated with diseases of the CNS: new developments and future challenges, The Lancet Neurology, vol.10, issue.8, pp.759-772, 2011. ,
DOI : 10.1016/S1474-4422(11)70096-5